ProMIS Neurosciences, Inc. (PMN)
9.035
+0.94
(+11.68%)
USD |
NASDAQ |
Oct 21, 16:00
9.035
0.00 (0.00%)
After-Hours: 18:10
ProMIS Neurosciences Market Cap : 81.02M for Oct. 21, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 20, 2026 | 72.55M |
| October 19, 2026 | 73.80M |
| October 16, 2026 | 73.09M |
| October 15, 2026 | 78.02M |
| October 14, 2026 | 74.30M |
| October 13, 2026 | 77.66M |
| October 12, 2026 | 84.74M |
| October 09, 2026 | 86.18M |
| October 08, 2026 | 82.05M |
| October 07, 2026 | 81.79M |
| October 06, 2026 | 82.59M |
| October 05, 2026 | 84.03M |
| October 02, 2026 | 84.30M |
| October 01, 2026 | 84.12M |
| September 30, 2026 | 97.30M |
| September 29, 2026 | 95.37M |
| September 28, 2026 | 95.51M |
| September 25, 2026 | 101.07M |
| September 24, 2026 | 103.76M |
| September 23, 2026 | 116.04M |
| September 22, 2026 | 121.78M |
| September 21, 2026 | 122.23M |
| September 18, 2026 | 125.64M |
| September 17, 2026 | 120.71M |
| September 16, 2026 | 115.50M |
| Date | Value |
|---|---|
| September 15, 2026 | 115.59M |
| September 14, 2026 | 118.91M |
| September 11, 2026 | 121.60M |
| September 10, 2026 | 120.17M |
| September 09, 2026 | 128.82M |
| September 08, 2026 | 112.37M |
| September 04, 2026 | 112.99M |
| September 03, 2026 | 115.68M |
| September 02, 2026 | 125.32M |
| September 01, 2026 | 119.72M |
| August 31, 2026 | 117.21M |
| August 28, 2026 | 123.62M |
| August 27, 2026 | 125.46M |
| August 26, 2026 | 129.67M |
| August 25, 2026 | 137.74M |
| August 24, 2026 | 132.72M |
| August 21, 2026 | 130.12M |
| August 20, 2026 | 133.71M |
| August 19, 2026 | 131.47M |
| August 18, 2026 | 134.34M |
| August 17, 2026 | 131.47M |
| August 14, 2026 | 133.26M |
| August 13, 2026 | 132.63M |
| August 12, 2026 | 130.03M |
| August 11, 2026 | 134.25M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Edesa Biotech, Inc. | 26.39M |
| Arrowhead Pharmaceuticals, Inc. | 8.303B |
| Oncolytics Biotech, Inc. | 64.09M |
| Sangamo Therapeutics, Inc. | 45.57M |
| Sarepta Therapeutics, Inc. | 1.961B |
Market Cap Related Metrics
| PEG Ratio | -0.0082 |
| Price to Book Value | 1.640 |
| Price | 9.035 |
| Earnings Yield | -148.7% |
| PEGY Ratio | -0.0082 |